CODX beat EPS expectations by 28.70%
May 09, 2025, 10:33 AM
0.00%
What does CODX do
CoDiagnostics, based in Salt Lake City, develops molecular tools for infectious disease detection, cancer screening, and agriculture, employing 155 staff. The company went public in July 2017 and is creating a portable diagnostic system for at-home use.
CoDiagnostics (CODX) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, CoDiagnostics's actual EPS was -$0.24, beating the estimate of -$0.34 per share, resulting in a 28.70% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.